DOUBLE OUTLET RIGHT VENTRICLE
Clinical trials for DOUBLE OUTLET RIGHT VENTRICLE explained in plain language.
Never miss a new study
Get alerted when new DOUBLE OUTLET RIGHT VENTRICLE trials appear
Sign up with your email to follow new studies for DOUBLE OUTLET RIGHT VENTRICLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common heart drug spark new muscle growth in babies with heart defects?
Disease control Recruiting nowThis early-stage trial tests whether the beta-blocker propranolol can stimulate heart muscle cell growth in infants born with Tetralogy of Fallot, a serious heart defect. Forty infants under 60 days old will receive propranolol, and researchers will measure new heart muscle cells…
Matched conditions: DOUBLE OUTLET RIGHT VENTRICLE
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New trial tests if operating on Newborns' hearts within 28 days beats waiting months
Disease control Recruiting nowThis study compares two surgical timings for babies born with Tetralogy of Fallot, a serious heart defect. One group gets corrective surgery within 28 days of birth, the other at the usual 3-6 months. Researchers will track deaths, reoperations, and recovery to see if earlier sur…
Matched conditions: DOUBLE OUTLET RIGHT VENTRICLE
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:49 UTC